Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study
Ocular Oncology and Pathology · 2017 · 3 (2) · 149-155
DOI: 10.1159/000453617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 29.12.2016. Verfasst von Francis L Munier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jules-Gonin Eye Hospital, University of Lausanne, Switzerland. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The anterior chamber has been shown by pharmacokinetic studies to represent a sanctuary never achieving a tumoricidal dose with the present administration routes, such as systemic, intra-arterial, or intravitreal injections.
Method
A novel intracameral chemotherapy technique is described to control aqueous seeding in a pilot unilateral group E retinoblastoma case with primary aqueous seeding. Anterior segment toxicity was carefully monitored.
Results
Control of the retinal tumor and vitreous seeding was achieved by intra-arterial and intravitreal chemotherapies. Sterilization of the aqueous was achieved after a first cycle of 7 melphalan injections in the anterior chamber, but relapse was noted 3.5 months later. This relapse was finally controlled with a second cycle of 6 intracameral injections targeting the posterior chamber. Corneal endothelial cell density remained stable over the injection period. Heterochromia and a progressive cataract developed, which required cataract surgery. At 5 years' follow-up, the patient is tumor free with normal vision (20/20 in both eyes), full binocularity, and no metastasis.
Conclusions
The present bicameral injection technique appears to be safe and effective with limited toxicity. Melphalan-induced side effects were noted on the iris and lens but with no impact on the final visual function.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jules-Gonin Eye Hospital, University of Lausanne, Switzerland.
- Institute of Pathology, University of Lausanne, Switzerland.
- Unit of Pediatric Hematology-Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Zitieren
APA
Munier, F. L., Gaillard, M. C., Decembrini, S., Bongiovanni, M., & Beck-Popovic, M. (2017). Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study. Ocular Oncology and Pathology, 3(2), 149-155. https://doi.org/10.1159/000453617
Vancouver
Munier FL, Gaillard MC, Decembrini S, Bongiovanni M, Beck-Popovic M. Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study. Ocular Oncology and Pathology. 2017;3(2):149-155. doi:10.1159/000453617
BibTeX
@article{Munier2017,
author = {Munier, Francis L and Gaillard, Marie-Claire and Decembrini, Sarah and Bongiovanni, Massimo and Beck-Popovic, Maja},
title = {Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study},
journal = {Ocular Oncology and Pathology},
year = {2017},
volume = {3},
number = {2},
pages = {149--155},
doi = {10.1159/000453617}
}
EUVIMED